BGMD (BG Medicine) EBITDA Margin %: -304.83% (As of Dec. 2015)


What is BG Medicine EBITDA Margin %?

BG Medicine BGMD -99.00% EBITDA Margin % is -304.83% as of Dec. 2015.

EBITDA Margin % is calculated as EBITDA divided by its Revenue. BG Medicine's EBITDA for the three months ended in Dec. 2015 was $-0.88 Mil. BG Medicine's Revenue for the three months ended in Dec. 2015 was $0.29 Mil. Therefore, BG Medicine's EBITDA margin for the quarter that ended in Dec. 2015 was -304.83%.

BG Medicine  (OTCPK:BGMD) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.

BG Medicine EBITDA Margin % Related Terms

BG Medicine EBITDA Margin % Historical Data

* Premium members only.

The historical data trend for BG Medicine's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

BG Medicine EBITDA Margin % Chart

BG Medicine Annual Data
Trend Dec05 Dec06 Dec08 Dec09 Dec10 Dec11 Dec12 Dec13 Dec14 Dec15
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -1,044.86 -796.20 -356.40 -258.52 -322.92

BG Medicine Quarterly Data
Mar11 Jun11 Sep11 Dec11 Mar12 Jun12 Sep12 Dec12 Mar13 Jun13 Sep13 Dec13 Mar14 Jun14 Sep14 Dec14 Mar15 Jun15 Sep15 Dec15
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -209.03 -280.78 -384.75 -300.00 -304.83

BGMD vs LENSF, WHSI, ASNB: EBITDA Margin % Comparison

For the Medical Instruments & Supplies subindustry, BG Medicine's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

BG Medicine EBITDA Margin % vs Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, BG Medicine's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where BG Medicine's EBITDA Margin % falls into.


BG Medicine EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

BG Medicine's EBITDA Margin % for the fiscal year that ended in Dec. 2015 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2015 )/Revenue (A: Dec. 2015 )
=-5.057/1.566
=-322.92 %

BG Medicine's EBITDA Margin % for the quarter that ended in Dec. 2015 is calculated as

EBITDA Margin %=EBITDA (Q: Dec. 2015 )/Revenue (Q: Dec. 2015 )
=-0.884/0.29
=-304.83 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about EBITDA Margin % →
What does a EBITDA Margin % of -304.83% mean?
BG Medicine (BGMD) has a EBITDA Margin % of -304.83% as of Dec. 2015. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on BG Medicine and its competitors.
Is BG Medicine's EBITDA Margin % too high?
BG Medicine's current EBITDA Margin % is -304.83%.
How does BG Medicine's EBITDA Margin % compare to LENSF and WHSI?
BG Medicine's EBITDA Margin % of -304.83% can be compared against companies in the Medical Devices & Instruments industry. The industry median EBITDA Margin % is 7.48. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good EBITDA Margin % for a Medical Devices & Instruments company?
The median EBITDA Margin % among Medical Devices & Instruments companies is 7.48, based on 816 companies in the industry. Companies in the top quartile (top 25%) have a EBITDA Margin % significantly above this median, while those in the bottom quartile fall well below. However, EBITDA Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high EBITDA Margin % mean?
A high EBITDA Margin % can signal that a stock is expensive relative to its fundamentals. EBITDA Margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent. View historical data on BG Medicine and its competitors. For the Medical Devices & Instruments industry, the median EBITDA Margin % is 7.48 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. BG Medicine's current EBITDA Margin % is -304.83%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is BG Medicine stock overvalued right now?
BG Medicine (BGMD) has a current EBITDA Margin % of -304.83%. The current EBITDA Margin % is -304.83%. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is EBITDA Margin % calculated?
EBITDA Margin % is calculated from a company's financial statements. For BG Medicine (BGMD), the current EBITDA Margin % is -304.83% as of Dec. 2015. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

BG Medicine Business Description

Address 303 Wyman Street, Suite 300, Waltham, MA, USA, 02451
BG Medicine Inc manufacture and sell diagnostic products that are used to guide the patients suffering from heart failure and related disorders in the United States. It distributes its products such as BGM Galectin-3 Test, an in vitro diagnostic device that measures galectin-3 in serum or plasma by enzyme-linked immunosorbent assay on a microtiter plate platform; and CardioSCORE Test, a multi-analyte biomarker-based blood test used for the assessment of near-term risk of atherothrombotic cardiovascular events, such as heart attack and ischemic stroke.